NCT04477317View on ClinicalTrials.gov

Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

October 30, 2021

Conditions
Local Anesthesia
Interventions
DRUG

4% Articaine Hydrochloride with 1:100,000 Adrenaline

new Egyptian articane anesthetic solution.

DRUG

2% Mepivacaine Hydrochloride with 1:20,000 Levonordefrin

Mepecaine-L is the brand name of the Egyptian 2% Mepivacaine. It is the most commonly used anesthetic solution in Egypt due to its availability and its lower cost.

Trial Locations (1)

Unknown

Faculty of dentistry cairo university, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04477317 - Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in Children | Biotech Hunter | Biotech Hunter